Vaidya Sane Ayurved Laboratories
MADHAVBAUG NSE
Vaidya Sane Ayurved Laboratories
HealthcareNSE: MADHAVBAUG Medical Equipment
Key Fundamentals
SMEMedical EquipmentHealthcareMarket Cap
₹167 Cr
Volatility
Moderate
P/E Ratio
18.6
EBITDA
₹15.42 Cr
Return on Equity
11.44%
Debt to Equity
0.03
Book Value
₹83.16
52W High
₹335
52W Low
₹147
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
3- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 10.2% over last 3 years.
- Working capital days have increased from 41.3 days to 112 days
Growth Rate
Revenue Growth
16.59% higher than
3Y
Net Income Growth
20.97% lower than
3Y
Cash Flow Change
941%
ROE
220% higher than
3Y
ROCE
185% higher than
3Y
EBITDA Margin (Avg.)
-15.76% lower than
3Y
Quarterly Results
| Particulars | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 46 | 54 | 51 | 48 | 42 | 48 | 50 | 57 |
| Expenses | 41 | 50 | 48 | 46 | 36 | 40 | 41 | 50 |
| Operating Profit | 4 | 4 | 3 | 2 | 6 | 9 | 9 | 7 |
| OPM % | 9% | 7% | 5% | 3.8% | 14% | 18% | 17% | 12% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 |
| Depreciation | 1 | 1 | 2 | 2 | 2 | 2 | 3 | 3 |
| PBT | 4 | 3 | 2 | 1 | 5 | 5 | 6 | 4 |
| Tax % | 27% | 23% | 25% | 37% | 21% | 34% | 25% | 4% |
| Net Profit | 3 | 2 | 1 | 1 | 4 | 3 | 5 | 4 |
| EPS in Rs | 2.6 | 1.99 | 1.12 | 0.76 | 3.58 | 3.21 | 4.59 | 3.96 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 99 | 99 | 90 | 107 |
| Expenses | 91 | 95 | 76 | 91 |
| Operating Profit | 9 | 5 | 13 | 15 |
| OPM % | 9% | 4.5% | 15% | 14% |
| Other Income | 1 | 2 | 1 | 2 |
| Interest | 1 | 0 | 0 | 1 |
| Depreciation | 3 | 3 | 4 | 6 |
| PBT | 6 | 3 | 10 | 11 |
| Tax % | 25% | 30% | 28% | 17% |
| Net Profit | 5 | 2 | 7 | 9 |
| EPS in Rs | 4.59 | 1.88 | 6.8 | 8.55 |
| Div. Payout % | 5% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 |
| Reserves | 30 | 45 | 52 | 77 |
| Borrowings | 0 | 2 | 1 | 3 |
| Other Liabilities | 14 | 12 | 13 | 14 |
| Total Liabilities | 55 | 70 | 77 | 105 |
| Fixed Assets | 21 | 28 | 34 | 35 |
| CWIP | 2 | 2 | 1 | 2 |
| Investments | 15 | 18 | 21 | 40 |
| Other Assets | 17 | 21 | 20 | 28 |
| Total Assets | 55 | 70 | 77 | 105 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | 0 | -1 | 11 | 5 |
| Investing | 1 | -13 | -10 | -24 |
| Financing | -1 | 15 | -1 | 17 |
| Net Cash Flow | -1 | 1 | 0 | -2 |
| Free Cash Flow | -7 | -12 | 2 | -2 |
| CFO/OP | 31 | -9 | 93 | 49 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 22 | 22 | 31 | 35 |
| Inventory Days | — | 58 | 82 | 70 |
| Days Payable | — | 101 | 149 | 127 |
| Cash Conversion Cycle | 22 | -20 | -37 | -21 |
| Working Capital Days | -2 | 5 | 7 | 112 |
| ROCE % | — | 6% | 18% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vaidya Sane Ayurved Laboratories insights
57 extracted metrics + investor summaries across FY19–FY26.
Documents
1
General Updates
9 Sep - Newspaper ads published for 27th AGM notice, annual report dispatch, remote e-voting, and book closure on September 9, 2026. 9 Sep - Newspaper ads published for 27th AGM notice, annual report dispatch, remote e-voting, and book closure on September 9, 2026.
2
Shareholders meeting
5 Sep - Annual report FY26 and AGM notice for 30 Sep 2026; book closure 23-30 Sep, e-voting 27-29 Sep. 5 Sep - Annual report FY26 and AGM notice for 30 Sep 2026; book closure 23-30 Sep, e-voting 27-29 Sep.
3
Outcome of Board Meeting
4 Sep - Board approved 30 Sep 2026 AGM, reappointments, remuneration hike, and 3 lakh-share ESOP 2026. 4 Sep - Board approved 30 Sep 2026 AGM, reappointments, remuneration hike, and 3 lakh-share ESOP 2026.
4
Statement of deviation(s) or variation(s) under Reg. 32
18 Aug - Filed August 18, 2026 statement of deviation or variation in public issue fund utilisation. 18 Aug - Filed August 18, 2026 statement of deviation or variation in public issue fund utilisation.
5
Outcome of Board Meeting
24 Jul - Rohit Madhav Sane resigns as CEO on 23 July 2026; D. Ramakrishna appointed CEO from 24 July 2026. 24 Jul - Rohit Madhav Sane resigns as CEO on 23 July 2026; D. Ramakrishna appointed CEO from 24 July 2026.
Frequently Asked Questions about Vaidya Sane Ayurved Laboratories
What does Vaidya Sane Ayurved Laboratories Ltd do?
Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running
of hospitals & clinics, and sale of Ayurved based medicines[1]
Where is Vaidya Sane Ayurved Laboratories Ltd (MADHAVBAUG) listed?
Vaidya Sane Ayurved Laboratories Ltd trades as MADHAVBAUG on the NSE.
Which sector does Vaidya Sane Ayurved Laboratories Ltd belong to?
Vaidya Sane Ayurved Laboratories Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the market capitalisation of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd has a market capitalisation of ₹167.11 Cr, which places it in the Small Cap band.
What is the PE ratio of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd trades at a PE ratio of 18.60, against a book value of ₹83.16 per share.
What is the 52-week high and low of Vaidya Sane Ayurved Laboratories Ltd?
Over the last 52 weeks Vaidya Sane Ayurved Laboratories Ltd has traded between ₹147 and ₹335.
Does Vaidya Sane Ayurved Laboratories Ltd pay dividends?
Vaidya Sane Ayurved Laboratories Ltd has a dividend yield of 0.31%.
What is the Return on Equity (ROE) of Vaidya Sane Ayurved Laboratories Ltd?
Vaidya Sane Ayurved Laboratories Ltd reported a return on equity of 11.44%. Its debt-to-equity ratio is 0.03.
Company Information
Incorporated in 2006, Vaidya Sane Ayurved Laboratories Ltd is the business of running of hospitals & clinics, and sale of Ayurved based medicines[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/MADHAVBAUG.md for Vaidya Sane Ayurved Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.